Prevention of low cardiac output syndrome in children: Where is the evidence?

Paediatric Anaesthesia

Volumn 21, Issue 12, 2011, Pages 1173-1175

  Van Saet, Annewil ^a,b   De Wildt, Saskia N ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; ENOXIMONE; GLYCERYL TRINITRATE; INOTROPIC AGENT; LEVOSIMENDAN; MILRINONE; NITROPRUSSIDE SODIUM; PHENOXYBENZAMINE; PLACEBO; VASODILATOR AGENT;

ARRHYTHMOGENESIS; CHILD; CHRONOTROPISM; DRUG EFFICACY; DRUG SAFETY; FORWARD HEART FAILURE; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HUMAN; INCIDENCE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK REDUCTION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VASODILATATION;

CARDIAC OUTPUT, LOW; CHILD; HUMANS;

EID: 80055014814     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2011.03700.x     Document Type: Review

References (26)

1. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002. (Pubitemid 36258723)
2. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92: 2226-2235.
3. De Oliveira NC, Ashburn DA, Khalid F, et al. Prevention of early sudden circulatory collapse after the Norwood operation. Circulation 2004; 110 (11 Suppl. 1): II133-II138. (Pubitemid 39263712)
4. Parr GV, Blackstone EH, Kirklin JW,. Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation 1975; 51: 867-874.
5. Vogt W, Läer S,. Prevention for paediatric low cardiac output syndrome: Results from the European survey EuLoCOS-Paed. Pediatr Anesth 2011; 21: 1176-1184.
6. Hoffman TM, Wernovsky G, Atz AM, et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics. Am Heart J 2002; 143: 15-21. (Pubitemid 34056369)
7. Stocker CF, Shekerdemian LS, Norgaard MA, et al. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Crit Care Med 2007; 35: 252-259. (Pubitemid 46035703)
8. Latifi S, Lidsky K, Blumer JL,. Pharmacology of inotropic agents in infants and children. Prog Pediatr Cardiol 2000; 12: 57-79.
9. Chang AC, Atz AM, Wernovski G, et al. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907-1914.
10. Colucci WS, Wright RF, Jaski BE, et al. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Circulation 1986; 2 (3 Pt 2): III175-III183.
11. Bohn D,. Objective assessment of cardiac output in infants after cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2011; 14: 19-23.
12. Bailey JM, Hoffman TM, Wessel DL, et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn 2004; 31: 43-59. (Pubitemid 38870189)
13. Zuppa AF, Nicolson SC, Adamson PC, et al. Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth Analg 2006; 102: 1062-1069.
14. Hoffman TM,. Newer inotropes in pediatric heart failure. J Cardiovasc Pharmacol 2011; 58: 121-125.
15. Osthaus WA, Boethig D, Winterhalter M, et al. First experiences with intraoperative Levosimendan in pediatric cardiac surgery. Eur J Pediatr 2009; 168: 735-740.
16. Egan JR, Clarke AJB, Williams S, et al. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med 2006; 21: 183-187.
17. Momeni M, Rubay J, Matta A, et al. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth 2011; 25: 419-424.
18. Gombotz H, Lechner E, Hofer A, et al. Levosimendan versus milrinone after biventricular corrective cardiac surgery in children. ASA Abstracts, 2010.
19. Turanlahti M, Boldt T, Palkama T, et al. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med 2004; 5: 457-462.
20. Appelbaum A, Blackstone EH, Kouchoukos NT, et al. Afterload reduction and cardiac ouptut in infants early after intracardiac surgery. Am J Cardiol 1977; 39: 445-451. (Pubitemid 8055363)
21. Kawamura M, Minamikawa O, Yokochi H, et al. Combined use of phenoxybenzamine and dopamine for low cardiac output syndrome in children at withdrawal from cardiopulmonary bypass. Br Heart J 1980; 43: 388-392. (Pubitemid 10083025)
22. Laitinen P, Happonen JM, Sairanen H, et al. Amrinone versus dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect. J Cardiothorac Vasc Anesth 1997; 11: 870-874. (Pubitemid 27523093)
23. Laitinen P, Happonen JM, Sairanen H, et al. Amrinone versus dopamine and nitroglycerin in neonates after arterial switch operation for transposition of the great arteries. J Cardiothorac Vasc Anesth 1999; 13: 186-190. (Pubitemid 29204946)
24. Howell NJ, Ashrafian H, Drury NE, et al. Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) trial. Circulation 2011; 123: 170-177.
25. Schroth M, Plank C, Meissner U, et al. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics 2006; 118: e76-e84. (Pubitemid 46074626)
26. Raja SG, Yousufuddin S, Rasool F, et al. Impact of modified ultrafiltration on morbidity after pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2006; 14: 341-350.